Glaxo’s Vaccines Chairman Moncef Slaoui to Retire Next YearBy
Slaoui to leave board in March, remain as adviser until July
Debruyne to continue to run Glaxo’s vaccine business
GlaxoSmithKline Plc’s vaccines division chief, Moncef Slaoui, will retire next year after a nearly 30-year career at the U.K.’s biggest drugmaker.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.